The history of Viagra, formerly marketed by copyright, presents a complex case study for stakeholders considering the drug arena . Although its initial success and impact of billions in earnings , the exclusivity end has opened the floodgates for generic medications, significantly eroding profit opportunities. This transition raises questions about